TAS6417

Item number	Size	Delivery time	Price
TGM-T16996-1mg	1 mg	7 - 10 business days*	84.00€
TGM-T16996-2mg	2 mg	7 - 10 business days*	119.00€
TGM-T16996-5mg	5 mg	7 - 10 business days*	187.00€
TGM-T16996-1mL	1 ml	7 - 10 business days*	213.00€
TGM-T16996-10mg	10 mg	7 - 10 business days*	310.00€
TGM-T16996-25mg	25 mg	7 - 10 business days*	627.00€
TGM-T16996-50mg	50 mg	7 - 10 business days*	1,004.00€
TGM-T16996-100mg	100 mg	7 - 10 business days*	1,545.00€
TGM-T16996-500mg	500 mg	7 - 10 business days*	3,111.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: TAS6417 is an EGFR inhibitor and is an efficacious drug candidate for patients with... more

Close menu

Product information "TAS6417"

Description: TAS6417 is an EGFR inhibitor and is an efficacious drug candidate for patients with NSCLC (IC50: ranging from 1.1-8.0 nM). Target: Apoptosis, EGFR. Smiles: CC1=C[C@@H](Cn2c1c(-c1cnc3ccccc3c1)c1c(N)ncnc21)NC(=O)C=C. References: Hasako S, et al. TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations. Mol Cancer Ther. 2018 Aug,17(8):1648-1658.

Supplier:	TargetMol
Supplier-Nr:	T16996

Properties

Application:	Pan-EGFR inhibitor
MW:	396.44 D
Formula:	C23H20N6O

Database Information

CAS :	1661854-97-2\| Matching products
KEGG ID :	K04361 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "TAS6417"

Write a review